AFT Pharmaceuticals Ltd
NZX:AFT
Wall Street
Price Targets
AFT Price Targets Summary
AFT Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for AFT is 4.39 NZD with a low forecast of 4.14 NZD and a high forecast of 4.73 NZD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFT's stock price target?
Price Target
4.39
NZD
According to Wall Street analysts, the average 1-year price target for AFT is 4.39 NZD with a low forecast of 4.14 NZD and a high forecast of 4.73 NZD.
What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
18%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 18%.
What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
29%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's operating income is 26%. The projected CAGR for the next 3 years is 29%.
What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
30%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's net income is 43%. The projected CAGR for the next 3 years is 30%.
